{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:43:24Z","timestamp":1794055404402,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["21808226"],"award-info":[{"award-number":["21808226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["21821005"],"award-info":[{"award-number":["21821005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["31970872"],"award-info":[{"award-number":["31970872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.004","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T07:45:27Z","timestamp":1581320727000},"page":"2478-2486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines"],"prefix":"10.1016","volume":"38","author":[{"given":"Shuai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.004_b0005","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1016\/j.vaccine.2006.10.052","article-title":"Global FMD control - Is it an option?","volume":"25","author":"Kitching","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.vaccine.2014.02.061","article-title":"Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant","volume":"32","author":"Quattrocchi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0015","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2147\/IJN.S72318","article-title":"Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles","volume":"9","author":"Pan","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2020.02.004_b0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/14760584.2016.1140042","article-title":"Foot-and-mouth disease vaccines: progress and problems","volume":"15","author":"Cao","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.02.004_b0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/tbed.12521","article-title":"Global foot-and-mouth dDisease research update and gap analysis: 3-Vaccines","volume":"63","author":"Robinson","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2020.02.004_b0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1586\/14760584.2014.963562","article-title":"Adjuvants for foot-and-mouth disease virus vaccines: recent progress","volume":"13","author":"Cao","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.02.004_b0040","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1016\/j.vaccine.2011.08.072","article-title":"CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle","volume":"29","author":"Ren","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/1348-0421.12567","article-title":"Soybean oil containing ginseng saponins as adjuvants promotes production of cytokines and enhances immune responses to foot-and-mouth disease vaccine","volume":"62","author":"Zhang","year":"2018","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijbiomac.2015.04.044","article-title":"Chuanminshen violaceum polysaccharides improve the immune responses of foot-and-mouth disease vaccine in mice","volume":"78","author":"Feng","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2008.10.030","article-title":"Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice","volume":"27","author":"Song","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rvsc.2013.11.017","article-title":"Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles","volume":"96","author":"Chen","year":"2014","journal-title":"Res Vet Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.004_b0065","article-title":"Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine","volume":"10","author":"Zhou","year":"2014","journal-title":"Bmc Vet Res"},{"key":"10.1016\/j.vaccine.2020.02.004_b0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/21691401.2016.1188396","article-title":"Construction of a stable w\/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine","volume":"45","author":"Chen","year":"2017","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0075","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2008.11.078","article-title":"Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response","volume":"27","author":"Hansen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0080","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.vaccine.2017.03.037","article-title":"Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0085","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2015.03.066","article-title":"Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine","volume":"33","author":"Harmsen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01314726","article-title":"Comparative immunogenicity of 146s, 75s and 12s particles of foot-and-mouth-disease virus","volume":"73","author":"Doel","year":"1982","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"J Control Release"},{"issue":"305\u201313","key":"10.1016\/j.vaccine.2020.02.004_b0100","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.vaccine.2020.02.004_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: Production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2020.02.004_b0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vetpar.2015.07.005","article-title":"Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis","volume":"212","author":"Shahbazi","year":"2015","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.01.010","article-title":"Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms","volume":"201","author":"De Jesus","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2020.02.004_b0120","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1016\/S0142-9612(02)00216-8","article-title":"Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells","volume":"23","author":"Erni","year":"2002","journal-title":"Biomaterials"},{"issue":"495\u2013509","key":"10.1016\/j.vaccine.2020.02.004_b0125","article-title":"Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route","volume":"13","author":"Mishra","year":"2010","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.vaccine.2020.02.004_b0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(96)04731-X","article-title":"Biodegradation of solid lipid nanoparticles as a function of lipase incubation time","volume":"144","author":"Muller","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2020.02.004_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pep.2015.04.011","article-title":"A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus","volume":"113","author":"Li","year":"2015","journal-title":"Protein Expression Purif"},{"key":"10.1016\/j.vaccine.2020.02.004_b0140","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.vaccine.2015.01.031","article-title":"Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens","volume":"33","author":"Yang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0145","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.actbio.2011.03.023","article-title":"Polyanhydride microparticles enhance dendritic cell antigen presentation and activation","volume":"7","author":"Torres","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.vaccine.2020.02.004_b0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles, Production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.vaccine.2020.02.004_b0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2015.04.011","article-title":"The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs)","volume":"235","author":"Hwang","year":"2015","journal-title":"Chem-Biol Interact"},{"key":"10.1016\/j.vaccine.2020.02.004_b0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/jmbi.1997.1418","article-title":"Titration calculations of foot-and-mouth disease virus capsids and their stabilities as a function of pH","volume":"275","author":"van Vlijmen","year":"1998","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0165","doi-asserted-by":"crossref","first-page":"13933","DOI":"10.1039\/C9RA02722J","article-title":"Unique stabilizing mechanism provided by biocompatible choline-based ionic liquids for inhibiting dissociation of inactivated foot-and-mouth disease virus particles","volume":"9","author":"Lin","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.vaccine.2020.02.004_b0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.colsurfb.2014.12.032","article-title":"Rational design of didodecyldimethylammonium bromide-based nanoassemblies for gene delivery","volume":"126","author":"Jin","year":"2015","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.vaccine.2020.02.004_b0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nmat5057","article-title":"Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination","volume":"17","author":"Xia","year":"2018","journal-title":"Nat Mater"},{"key":"10.1016\/j.vaccine.2020.02.004_b0185","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1016\/j.vaccine.2010.06.098","article-title":"Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice","volume":"28","author":"Batista","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.004_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.intimp.2016.07.012","article-title":"The potential adjuvanticity of quaternized chitosan hydrogel based microparticles for porcine reproductive and respiratory syndrome virus inactivated vaccine","volume":"39","author":"Wang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/smvy.1995.0029","article-title":"Antibody recognition and neutralization of foot-and-mouth-disease virus","volume":"6","author":"Brown","year":"1995","journal-title":"Semin Virol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1966","article-title":"Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host","volume":"28","author":"Abubakar","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: Function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.02.004_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030435","article-title":"Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response","volume":"7","author":"Schley","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:41Z","timestamp":1759401581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20301572"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}